Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. - Wikidata - wikimedia - TriplyDB

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.

http://www.wikidata.org/entity/Q33212600

about

Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer Recurrent rearrangements in prostate cancer: causes and therapeutic potential Discovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate Tissue Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin.Prognostic outlier genes for enhanced prostate cancer treatment.Evaluation of the 8q24 prostate cancer risk locus and MYC expression.Cancer biomarker discovery: the entropic hallmark.TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling.Androgen responsive intronic non-coding RNAs Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.Prostate cancer-associated gene expression alterations determined from needle biopsies.Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status.Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development.Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence.Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion.Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer Epithelial-mesenchymal transition in prostate cancer: an overview.Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells Evaluation of ERG responsive proteome in prostate cancer Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer Regulation of androgen-responsive transcription by the chromatin remodeling factor CHD8.Antibody-based detection of ERG rearrangement-positive prostate cancer Prostate tumor development and androgen receptor function alterations in a new mouse model with ERG overexpression and PTEN inactivation Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer.Predominance of ERG-negative high-grade prostate cancers in African American men.5' UTR control of native ERG and of Tmprss2:ERG variants activity in prostate cancer ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods.miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.JunD-mediated repression of GADD45α and γ regulates escape from cell death in prostate cancer Reconstitution of the ERG Gene Expression Network Reveals New Biomarkers and Therapeutic Targets in ERG Positive Prostate Tumors

P2860

Q24629083-CC49C24B-499D-4BB9-9A17-BE9D2A1F9094 Q24676201-FDEDE226-08BC-4C00-8C69-52A9117622C4 Q26752933-04998DD7-B5EB-49E0-AC43-78356F4F52C3 Q26851525-E0544A05-A65A-4C05-933B-A12C996616B4 Q26997884-1B7F296C-D4AD-4ECA-802D-D86D5C7E0C10 Q28269917-0ACCF4AE-2E8B-4526-AEA0-1034B237F1D9 Q28546607-27919340-D28E-4ABC-9F44-134D6B57B41A Q28771711-73AFD7C1-0CC4-4F61-9851-9006C87652E4 Q30244674-C5F1FC56-8B73-4C88-901E-A1FC2FEB1358 Q30494853-47D582CF-F9CE-4558-93C5-AC5DB02F9C75 Q30496149-F623C0C6-B3F2-4090-8EDE-42CE4296B6EC Q31042968-8682E6AF-110F-4333-891C-B0502B4FAFFF Q33270960-7D93E7DA-92A6-413E-BC21-E7B55502B857 Q33359279-40F28B6A-E31F-4D7E-94AF-7E9A599B7B21 Q33430210-FA302611-C090-4498-86A5-77F9ACAE03DB Q33567270-07F3551E-5050-43CA-9CF4-115A8D1C3B0C Q33645816-242FDB7B-CB9A-4BC0-9F54-93218CB3CE5F Q33663401-1E85FEE3-EB6C-4128-A5CE-5D2E4717D4B0 Q33682349-9EAB3C92-4731-4AD8-8990-6093609037EA Q33685303-ABF34316-4A92-48F4-839C-B3B0FD6815A8 Q33714055-7AEA56D4-3573-4F62-A45A-2706C06AE1D0 Q33723651-C9F63CA3-F9CB-45EA-BF26-B0A883D33F59 Q33772417-742D2377-F8B9-438E-9FFC-CC1991FBCEB9 Q33784622-E3FAB6B5-D926-45CB-8545-BB6DECC9C5B5 Q33798864-FAB28476-0FBF-4183-BB50-55FD5C7CC2F0 Q33803926-32F63B3F-C5C4-4059-842B-6F2D870BE434 Q33822319-C6DFEBC8-6661-4E05-9E6D-389822BE5089 Q33852664-4BF26961-3769-4550-BB1C-13D374BF49A4 Q33862890-8C978B08-3B92-4216-9457-B354A690C8BC Q33874370-CB5388A4-F13F-4A3B-99D9-D1BE41B24C59 Q34009867-3DA7E29D-884C-45C2-981B-3D9C9629B7AA Q34036065-FFA63ED8-C263-48CD-95B2-84E10B345A5B Q34170544-B67737B9-6E0D-4C2B-9A0F-55327B02AD49 Q34265721-C7013C49-7D10-4F9F-8D6E-0EBB7EFA84F8 Q34614232-F951FF9E-AE81-4218-846B-04CB1669A05F Q35108911-9F3B3F0D-CE45-46DB-93D3-E10650812274 Q35125405-BDA96505-5568-4BAE-8A5E-12AC0A0E4C31 Q35207623-C82AFD67-2F90-40B0-A61C-1B6F0EEE1327 Q35232584-77A0AA18-D75F-453A-92D9-67243B942000 Q35631603-6E3E03E1-80AE-48FC-BBEB-8EEBD8288481

P2860

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.

http://www.wikidata.org/entity/Q33212600

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.

@ast

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.

@en

type

label

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.

@ast

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.

@en

prefLabel

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.

@ast

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.

@en

P1433

Q33212600-BAA8743E-45EC-4779-9AE5-F3879FEC868B

P1476

Q33212600-407C8248-8E02-44B4-A129-118873E84A96

P2093

Q33212600-046BD668-25DE-4967-AEFB-18FFDD57602F

Q33212600-10AC88EC-7CA9-4C28-9290-AB76A643E0CC

Q33212600-1BECED77-DD34-4C8C-8850-CADD9694E965

Q33212600-2AD5197B-DFC7-446F-A5A4-7BDBC97550D4

Q33212600-2C6173B9-AF39-40E5-BF0F-75EE0509CF39

Q33212600-3382B6C3-53BF-434C-9FC6-2F643146C12D

Q33212600-3BC053F3-1BBF-4992-873B-569B1E309BB2

Q33212600-44274A89-D982-456F-9B29-5ED6131D778C

Q33212600-44F8886C-ACF4-48BE-8614-31ECF967588C

Q33212600-4D0139E6-E4B8-4F4E-A198-8BFFBFB4FA4C

P2860

Q33212600-10679791-5303-4974-BBFB-41D9483AC584

Q33212600-1BC3A8A3-2841-4B16-A4CA-B76A50BDB669

Q33212600-3250C236-B571-46D3-8078-89F41859784D

Q33212600-4296CD36-365C-4E4C-87BD-29C7BAF8570A

Q33212600-44114E5A-D7BC-4957-B6AD-8E34F382DF2D

Q33212600-76C57D6D-9141-4905-BCCC-82C0CFF3051D

Q33212600-7B9EFB37-5E5B-4791-8C1D-DA36A82FAC2C

Q33212600-8C0A1891-7EF4-4C5D-AC56-3C7F0AF5634F

Q33212600-8E5B511A-B0AF-44FC-B397-32C949BE4A6F

Q33212600-CCA7B76A-9997-423B-A1EA-8AC1E10A9A3D

P2888

Q33212600-8923A5E2-369E-4357-AB50-AD116FA054A1

P304

Q33212600-E2247F4E-12BB-480C-8225-BB8C9C78714D

P31

Q33212600-F491E469-45B9-4BFB-8396-C7ECA1ABE27C

P356

Q33212600-5CAE7A67-37B5-4202-B7AB-A4530BB284F9

P407

Q33212600-0E081A20-F045-4CB2-B12E-08F15866A350

P433

Q33212600-803C47B5-ABF4-4BE6-BE2B-BEAAFCB47AE5

P478

Q33212600-0217A3BF-F2FB-4A46-BB3A-2840E1217107

P577

Q33212600-85496B8F-6E45-49BA-9D5D-91F1B8DBB3DD

P5875

Q33212600-5301C492-AC47-4014-B294-E106E9980D17

P6179

Q33212600-860AB8AA-0C3A-469E-984F-D80AAE86D861

P698

Q33212600-1E25BAF6-52D5-4AA7-9201-F6168931F25D

P921

Q33212600-24FC1230-2FDA-4731-BDFF-6F7D663A8992

Q33212600-E6DF8022-5674-4022-B4F9-CC7ABE3E15F3

P356

P1433

P1476

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.

@en

P2093

Aijun Liu

http://www.w3.org/2001/XMLSchema#string

Albert Dobi

http://www.w3.org/2001/XMLSchema#string

Bungo Furusato

http://www.w3.org/2001/XMLSchema#string

Chen Sun

http://www.w3.org/2001/XMLSchema#string

David G McLeod

http://www.w3.org/2001/XMLSchema#string

Gyorgy Petrovics

http://www.w3.org/2001/XMLSchema#string

Isabell A Sesterhenn

http://www.w3.org/2001/XMLSchema#string

Judd W Moul

http://www.w3.org/2001/XMLSchema#string

Lakshmi Ravindranath

http://www.w3.org/2001/XMLSchema#string

Martin Nau

http://www.w3.org/2001/XMLSchema#string

P2860

The erg gene: a human gene related to the ets oncogene

Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma

Delineation of prognostic biomarkers in prostate cancer

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.

Molecular biology of the Ets family of transcription factors.

Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients.

Oncogenes and tumor suppressor genes in prostate cancer.

Searching for the gatekeeper oncogene of prostate cancer.

Ets proteins in biological control and cancer.

Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes.

P2888

P304

3847-3852

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1208518

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7982862

http://www.w3.org/2001/XMLSchema#string

P6179

1018432896

http://www.w3.org/2001/XMLSchema#string

P698

15750627

http://www.w3.org/2001/XMLSchema#string

P921